Liposomal delivery of proteins and peptides
暂无分享,去创建一个
[1] Yvonne Perrie,et al. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[2] J. Goerke,et al. Pulmonary surfactant: functions and molecular composition. , 1998, Biochimica et biophysica acta.
[3] K. Ito,et al. Influence of liposomes on tryptic digestion of insulin. , 1993, Biological & pharmaceutical bulletin.
[4] B. Wollenberg,et al. Liposomal transfection of squamous carcinoma cells of the head and neck with IL-2 and B7 plasmids inducing an autologous immune response in vitro. , 2005, Anticancer research.
[5] C. Ehrhardt,et al. Liposomes for Pulmonary Drug Delivery , 2011 .
[6] K. Skubitz,et al. Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial , 2000, Anti-cancer drugs.
[7] M. Kisel,et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. , 2001, International journal of pharmaceutics.
[8] I. Rubinstein,et al. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. , 1995, Life sciences.
[9] N. Das,et al. Oral application of insulin encapsulated liposomes. , 1988, Biochemistry international.
[10] Y. Barenholz,et al. Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] J. Cherng,et al. ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES , 2001, Journal of liposome research.
[12] Yoshinori Kato,et al. In vivo efficacy of a novel double liposome as an oral dosage form of salmon calcitonin , 2003 .
[13] M. Naud,et al. Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes. , 2007, Investigative ophthalmology & visual science.
[14] F. Dosio,et al. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.
[15] H. Jacobsson,et al. Biodistribution of liposomal 131I-VIP in rat using gamma camera. , 2000, Nuclear Medicine and Biology.
[16] T. Yoshikawa,et al. A novel and simple type of liposome carrier for recombinant interleukin‐2 , 2001, The Journal of pharmacy and pharmacology.
[17] P. Diwan,et al. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery , 2007, Journal of drug targeting.
[18] S. Balu-Iyer,et al. Delivery of therapeutic proteins. , 2010, Journal of pharmaceutical sciences.
[19] R. Prassl,et al. Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. , 2007, Biochimica et biophysica acta.
[20] R. Prassl,et al. Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] Y. Barenholz,et al. Delivery of Cytokines by Liposomes. II. Interleukin‐2 Encapsulated in Long‐Circulating Sterically Stabilized Liposomes: Immunomodulatory and Anti‐Tumor Activity in Mice , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[22] J. Kawada,et al. Effects of oral administration of positively charged insulin liposomes on alloxan diabetic rats: preliminary study. , 1979, Endocrinologia japonica.
[23] C. Sharma,et al. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats , 2000, Journal of microencapsulation.
[24] Yan Liu,et al. Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery , 2009, Peptides.
[25] Laura Zanetti Polzi,et al. Calcitonin forms oligomeric pore-like structures in lipid membranes. , 2006, Biophysical journal.
[26] M. Naud,et al. Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats , 2007, Molecular vision.
[27] G. Storm,et al. Liposomes: quo vadis? , 1998 .
[28] E. Abraham,et al. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. , 1992, Journal of immunology.
[29] A. Annapragada,et al. Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats , 2007, International journal of nanomedicine.
[30] Q. Ping,et al. Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. , 2000, Drug delivery.
[31] C. Chew,et al. Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell. , 1998, American journal of physiology. Cell physiology.
[32] Y. Oh,et al. Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. , 1999, International journal of pharmaceutics.
[33] Ritesh Kumar,et al. Modified Transdermal Technologies: Breaking the Barriers of Drug Permeation via the Skin , 2007 .
[34] J. Bradshaw. Phosphatydylglycerol promotes bilayer insertion of salmon calcitonin. , 1997, Biophysical journal.
[35] L. Deftos,et al. Liposome entrapment enhances the hypocalcemic action of parenterally administered calcitonin. , 1984, Endocrinology.
[36] J. Parsons,et al. Prolonged Hypoglycemic Effect in Diabetic Dogs Due to Subcutaneous Administration of Insulin in Liposomes , 1982, Diabetes.
[37] T. Seki,et al. Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[38] Y. Barenholz,et al. Delivery of cytokines by liposomes: hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and in long-circulating liposomes. , 2000, Journal of immunotherapy.
[39] S. Kawakami,et al. Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice , 2010, Cancer Gene Therapy.
[40] M. Tsilimbaris,et al. Stability of Protein-Encapsulating DRV Liposomes After Freeze-Drying: A Study with BSA and t-PA , 2006, Journal of liposome research.
[41] T. Nagai,et al. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits. , 1999, Drug development and industrial pharmacy.
[42] Manisha Patel,et al. Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[43] P. Anderson,et al. Interleukin-2 liposomes for primary immune deficiency using the aerosol route. , 2002, International immunopharmacology.
[44] B. Dupuy,et al. Cholate-Induced Disruption of Calcitonin-Loaded Liposomes: Formation of Trypsin-Resistant Lipid-Calcitonin-Cholate Complexes , 1995, Pharmaceutical Research.
[45] T. Nagai,et al. High entrapment of insulin and bovine serum albumin into neutral and positively-charged liposomes by the remote loading method. , 2000, Chemical & pharmaceutical bulletin.
[46] T Nagai,et al. Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits. , 1992, Chemical & pharmaceutical bulletin.
[47] J. Bystryn,et al. Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice , 2006, Cancer Immunology, Immunotherapy.
[48] I. Sayek,et al. LIPOSOME-MEDIATED INTRAPERITONEAL INTERLEUKIN 10 GENE TRANSFER INCREASES SURVIVAL IN CECAL LITIGATION AND PUNCTURE MODEL OF SEPSIS , 2006, Shock.
[49] I. Rubinstein,et al. Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[50] M. Naud,et al. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[51] Jeong-Sook Park,et al. Encapsulation enhancement and stabilization of insulin in cationic liposomes. , 2011, International journal of pharmaceutics.
[52] P. Anderson,et al. Nebulized Interleukin 2 Liposomes: Aerosol Characteristics and Biodistribution , 1997, The Journal of pharmacy and pharmacology.
[53] Y. Kato,et al. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[54] Y. Kawashima,et al. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[55] T. Yoshikawa,et al. Continuous Release of Interleukin-2 from Liposomal IL-2 (Mixture of Interleukin-2 and Liposomes) After Subcutaneous Administration to Mice , 2003, Drug development and industrial pharmacy.
[56] A. F. Kotzé,et al. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride. , 2010, International journal of pharmaceutics.
[57] S. Yamashita,et al. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. , 1999, Journal of pharmaceutical sciences.
[58] T. Nagai,et al. Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. , 1996, Biological & pharmaceutical bulletin.
[59] M. C. Popescu,et al. Biopharmaceutics of liposomal interleukin 2, oncolipin. , 2000, Cytokine.
[60] Q. Ping,et al. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. , 2004, Acta pharmacologica Sinica.
[61] S. Antimisiaris,et al. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility. , 2006, Biomaterials.
[62] R. J. Kelleher,et al. IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments. , 2009, Clinical immunology.
[63] A. Duits,et al. Immunoadjuvant activity of a liposomal IL-6 formulation. , 1993, Vaccine.
[64] D. Hess,et al. Nebulizers: principles and performance. , 2000, Respiratory care.
[65] Y. Kawashima,et al. Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes , 1996, Pharmaceutical Research.
[66] Y. Kawashima,et al. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery. , 2006, Die Pharmazie.
[67] T Nagai,et al. Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods. , 1999, International journal of pharmaceutics.
[68] Ching-Hua Wang,et al. Pulmonary delivery of insulin by liposomal carriers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[69] J. Kling. Inhaled insulin's last gasp? , 2008, Nature Biotechnology.
[70] V. Labhasetwar,et al. Liposomes as a carrier for oral administration of insulin: effect of formulation factors. , 1994, Journal of microencapsulation.
[71] W. Ahn,et al. Topical delivery of interleukin‐13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis , 2009, The journal of gene medicine.
[72] Qun Wang,et al. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. , 2008, Journal of drug targeting.
[73] A. Weiner. Liposomes for protein delivery: selecting manufacture and development processes. , 1994, ImmunoMethods.
[74] X. Cao,et al. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene. , 1999, Journal of experimental & clinical cancer research : CR.
[75] G. Gregoriadis,et al. The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles. , 1998, Journal of drug targeting.
[76] I. Rubinstein,et al. Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ. , 1996, The American journal of physiology.
[77] M. Naud,et al. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis. , 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[78] S. Law,et al. Characterization of calcitonin-containing liposome formulations for intranasal delivery. , 2001, Journal of microencapsulation.
[79] T. Nagai,et al. Double Liposomes: Hypoglycemic Effects of Liposomal Insulin on Normal Rats , 2003, Drug development and industrial pharmacy.
[80] I. Rubinstein,et al. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity , 2003, Peptides.
[81] A. Ulrich. Biophysical Aspects of Using Liposomes as Delivery Vehicles , 2002, Bioscience reports.
[82] C. Shim,et al. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[83] T. Tadakuma,et al. Effect of liposomal interleukin‐2 on ascites‐forming rat hepatoma , 1992, Journal of surgical oncology.
[84] I. Rubinstein,et al. Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters. , 2006, International journal of pharmaceutics.
[85] K. Kanamura,et al. Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis. , 2011, International journal of pharmaceutics.
[86] I. Rubinstein,et al. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. , 1994, Life sciences.
[87] P. Anderson,et al. Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: canine studies. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[88] P. Perrin,et al. Enhancement of interleukin-2 activity by liposomes. , 1990, Vaccine.
[89] B. Weiss-Steider,et al. Characterization of cationic liposomes having IL-2 expressed on their external surface, and their affinity to cervical cancer cells expressing the IL-2 receptor , 2009, Journal of drug targeting.
[90] Y. Chebloune,et al. Therapy of ‘SHIV’ infected macaques with liposomes delivering antisense interleukin-4 DNA , 2006, AIDS.
[91] M. Bally,et al. Techniques for encapsulating bioactive agents into liposomes. , 1986, Chemistry and physics of lipids.
[92] Z. Değim,et al. The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. , 2004, Life sciences.
[93] S. Nakagawa,et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[94] Kozo Takayama,et al. Novel Mucosal Insulin Delivery Systems Based on Fusogenic Liposomes , 2005, Pharmaceutical Research.
[95] P. Anderson,et al. Interleukin‐2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases , 1997, Cancer.
[96] J. Cáceres-Cortés,et al. Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cells in vitro, and significantly reduced tumor burden in immunodepressed mice , 2011, Journal of drug targeting.
[97] A. Annapragada,et al. Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[98] G. Gregoriadis,et al. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo. , 1997, Immunology letters.
[99] Yuquan Wei,et al. Gene therapy for psoriasis in the K14‐VEGF transgenic mouse model by topical transdermal delivery of interleukin‐4 using ultradeformable cationic liposome , 2010, The journal of gene medicine.